These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32395664)

  • 21. Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials.
    Di Liello R; Piccirillo MC; Arenare L; Gargiulo P; Schettino C; Gravina A; Perrone F
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and analysis of umbrella trials: Where do we stand?
    Ouma LO; Wason JMS; Zheng H; Wilson N; Grayling M
    Front Med (Lausanne); 2022; 9():1037439. PubMed ID: 36313987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basket Designs: Statistical Considerations for Oncology Trials.
    Kaizer AM; Koopmeiners JS; Kane MJ; Roychoudhury S; Hong DS; Hobbs BP
    JCO Precis Oncol; 2019 Dec; 3():1-9. PubMed ID: 35100726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New clinical trial design in precision medicine: discovery, development and direction.
    Duan XP; Qin BD; Jiao XD; Liu K; Wang Z; Zang YS
    Signal Transduct Target Ther; 2024 Mar; 9(1):57. PubMed ID: 38438349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobilizing the clinical trial ecosystem to drive adoption of master protocols.
    Bronson A; Chase MK; Fisher K; Millar D; Perlmutter J; Richardson N
    Clin Trials; 2022 Dec; 19(6):690-696. PubMed ID: 36086812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology.
    Polley MC; Cheung YK
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32923846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges, opportunities, and innovative statistical designs for precision oncology trials.
    Yin J; Shen S; Shi Q
    Ann Transl Med; 2022 Sep; 10(18):1038. PubMed ID: 36267789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Types and progress of clinical trial design for breast cancer: a narrative review.
    Zhou T; Zhang J
    Transl Breast Cancer Res; 2023; 4():20. PubMed ID: 38751463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine.
    Moore DC; Guinigundo AS
    J Adv Pract Oncol; 2023 Apr; 14(Suppl 1):9-13. PubMed ID: 37206904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Master Protocols in Pediatric Drug Development.
    Nelson RM; Conklin LS; Komocsar WJ; Chen F; Williamson F; Crandall WV
    Ther Innov Regul Sci; 2022 Nov; 56(6):895-902. PubMed ID: 36045315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
    Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
    [No Abstract]   [Full Text] [Related]  

  • 34. Master protocols in lung cancer: experience from Lung Master Protocol.
    Lam VK; Papadimitrakopoulou V
    Curr Opin Oncol; 2018 Mar; 30(2):92-97. PubMed ID: 29329112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer.
    Lam M; Loree JM; Pereira AAL; Chun YS; Kopetz S
    Curr Treat Options Oncol; 2018 Feb; 19(2):11. PubMed ID: 29488033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical Review of Umbrella, Basket, and Platform Designs for Oncology Clinical Trials.
    Simon R
    Clin Pharmacol Ther; 2017 Dec; 102(6):934-941. PubMed ID: 28795401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiencies of platform clinical trials: A vision of the future.
    Saville BR; Berry SM
    Clin Trials; 2016 Jun; 13(3):358-66. PubMed ID: 26908536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges and shifting paradigms in clinical trials in oncology: the case for immunological and targeted therapies.
    Sotelo-Rodríguez DC; Ruíz-Patiño A; Ricaurte L; Arrieta O; Zatarain-Barrón ZL; Cardona AF
    Ecancermedicalscience; 2019; 13():936. PubMed ID: 31552109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New clinical trial designs in the era of precision medicine.
    Garralda E; Dienstmann R; Piris-Giménez A; Braña I; Rodon J; Tabernero J
    Mol Oncol; 2019 Mar; 13(3):549-557. PubMed ID: 30698321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.